الفهرس | Only 14 pages are availabe for public view |
Abstract Ventilator associated pneumonia (VAP) is one of the most common hospital-acquired infection. Ventilator associated pneumonia occur in patients who require intubation and MV for more than 48 hours, it cause high morbidity, mortality, long hospital stay and excess costs. It is the second most common nosocomial infection in the PICU and the most common in mechanically ventilated patients. As there is lack of a gold standard for the diagnosis of VAP in both adult and children and it has poor prognosis, so the use of inflammatory serum biomarkers may aid in rapid detection of VAP, predicting the outcome in such patients and to guide the optimization of antibiotic and improve outcome. |